Premium
Studies at ASCO report results on newdrug therapies and survivorship issues
Author(s) -
Printz Carrie
Publication year - 2011
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.26400
Subject(s) - medicine , ipilimumab , vemurafenib , dacarbazine , bevacizumab , oncology , trametinib , melanoma , chemotherapy , temozolomide , immunotherapy , cancer , surgery , cancer research , metastatic melanoma , mapk/erk pathway , kinase , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom